Bristol Myers Squibb vs KAHR Medical
Bristol Myers Squibb vs KAHR Medical, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bristol Myers Squibb is on 22/100 and KAHR Medical on 35/100.
Where each one leads
Bristol Myers Squibb
- agent readiness: 44/100 against 21/100
- domain rating: 83/100 against 4/100
- headcount: 38,080 against 50
- LinkedIn following: 1,886,144 against 1,235
KAHR Medical
- our overall score: 35/100 against 22/100
At a glance
| Measure | Bristol Myers Squibb | KAHR Medical |
|---|---|---|
| What it is | A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. | Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Healthcare, Biotech, MedTech, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 1989 | 2011 |
| Headquarters | New York, United States | Jerusalem, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Bristol Myers Squibb | KAHR Medical |
|---|---|---|
| Employees | 38,080 | 50 |
| LinkedIn followers | 1,886,144 | 1,235 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bristol Myers Squibb | KAHR Medical |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 22/100 | 35/100 |
| Traction | 20/100 | 17/100 |
| Team | 10/100 | 30/100 |
| Search visibility | 23/100 | 22/100 |
| Quality | Not published | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 83/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bristol Myers Squibb | KAHR Medical |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | CloudFront | Not detected |
| Analytics | Microsoft Clarity, Qualtrics | Not detected |
What users say
| Measure | Bristol Myers Squibb | KAHR Medical |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 3 negative across 6 threads | Not published |
“Bristol Myers Squibb ist im Kurs gerade günstig und spuckt aktuell über 5% Rendite durch Dividende (vierteljährlich) im Jahr aus. Nichts aufregendes, aber ne solide Bank und nicht vergessen... mühsam ernährt sich das Eichhörnchen.”r/Aktien
Bristol Myers Squibb vs KAHR Medical: common questions
Which is better, Bristol Myers Squibb or KAHR Medical?
On our 0-100 score KAHR Medical rates higher (35/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Bristol Myers Squibb and KAHR Medical compare on the numbers?
Bristol Myers Squibb leads on agent readiness (44/100 against 21/100), domain rating (83/100 against 4/100), headcount (38,080 against 50), LinkedIn following (1,886,144 against 1,235). KAHR Medical leads on our overall score (35/100 against 22/100).
What do real users say about Bristol Myers Squibb and KAHR Medical?
Bristol Myers Squibb: 2 positive and 3 negative mentions across 6 Reddit threads we track, mostly in r/Aktien.
Read the full Bristol Myers Squibb review and pricing or the KAHR Medical review and pricing. You can also browse other Bristol Myers Squibb alternatives we track.